Correlation Between NYSE Composite and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Protalix Biotherapeutics, you can compare the effects of market volatilities on NYSE Composite and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Protalix Biotherapeutics.
Diversification Opportunities for NYSE Composite and Protalix Biotherapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NYSE and Protalix is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Protalix Biotherapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 28.98 times less return on investment than Protalix Biotherapeutics. But when comparing it to its historical volatility, NYSE Composite is 4.3 times less risky than Protalix Biotherapeutics. It trades about 0.02 of its potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 189.00 in Protalix Biotherapeutics on December 30, 2024 and sell it today you would earn a total of 69.00 from holding Protalix Biotherapeutics or generate 36.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Protalix Biotherapeutics
Performance |
Timeline |
NYSE Composite and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Protalix Biotherapeutics
Pair trading matchups for Protalix Biotherapeutics
Pair Trading with NYSE Composite and Protalix Biotherapeutics
The main advantage of trading using opposite NYSE Composite and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.NYSE Composite vs. Corby Spirit and | NYSE Composite vs. Church Dwight | NYSE Composite vs. Nascent Wine | NYSE Composite vs. Crocs Inc |
Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |